BioCentury | Apr 6, 2021
Finance

VCs led by HBM, Samsara back single-asset Mitsubishi Tanabe spinout Mineralys with $40M for hypertension program

...pressure, will be due in 2H22.Mineralys’ founder and chairman is Managing Partner BT Slingsby of Catalys Pacific...
...Healthcare Investments and Samsara BioCapital led the round, which also included Adams Street Partners and Catalys Pacific...
...NASDAQ:VRTX) as well as Novartis Institutes for Biomedical Research, where he was respiratory disease area translational medicine head.Catalys Pacific’s...
BioCentury | Jul 22, 2020
Finance

Shonan iPark venture consortium seeks to boost bets on Japanese biotechs

...and joint nurturing of entrepreneurial talent. Shonan Health Innovation Park named Takeda Ventures Inc. and Catalys Pacific...
...looking for a central location, Fujimoto said. Karen Tkach Tuzman, Associate Editor Takeda Pharmaceutical Co. Ltd. Takeda Ventures Inc. Catalys Pacific japan vc venture accelerator...
BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...an immune response in specific locations. Exalys debuts with $15M, Eisai deal Domain Associates and Catalys Pacific...
Items per page:
1 - 3 of 3
BioCentury | Apr 6, 2021
Finance

VCs led by HBM, Samsara back single-asset Mitsubishi Tanabe spinout Mineralys with $40M for hypertension program

...pressure, will be due in 2H22.Mineralys’ founder and chairman is Managing Partner BT Slingsby of Catalys Pacific...
...Healthcare Investments and Samsara BioCapital led the round, which also included Adams Street Partners and Catalys Pacific...
...NASDAQ:VRTX) as well as Novartis Institutes for Biomedical Research, where he was respiratory disease area translational medicine head.Catalys Pacific’s...
BioCentury | Jul 22, 2020
Finance

Shonan iPark venture consortium seeks to boost bets on Japanese biotechs

...and joint nurturing of entrepreneurial talent. Shonan Health Innovation Park named Takeda Ventures Inc. and Catalys Pacific...
...looking for a central location, Fujimoto said. Karen Tkach Tuzman, Associate Editor Takeda Pharmaceutical Co. Ltd. Takeda Ventures Inc. Catalys Pacific japan vc venture accelerator...
BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...an immune response in specific locations. Exalys debuts with $15M, Eisai deal Domain Associates and Catalys Pacific...
Items per page:
1 - 3 of 3